Picture of TELA Bio logo

TELA TELA Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Tela Bio Inc Reports Results For The Quarter Ended In June: Earnings Summary

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 57 cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 52 cents per share.
* Revenue rose 116.4% to $7.59 million from a year ago; 
analysts expected $6.31 million. 
* TELA Bio Inc's reported EPS for the quarter was a loss of 57
cents​.
* The mean earnings estimate of analysts had fallen by
about 3.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* TELA Bio Inc shares had fallen by 17.4% this quarter and
lost 11.5% so far this year.
* The company reported a quarterly loss of $8.26 million.
* Wall Street's median 12-month price target for TELA Bio Inc is
$20.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 08:48 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on TELA Bio

See all news